|
FAM96A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.874500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.114200E-01 |
| Normal-vs-Stage2 |
4.124200E-02 |
| Normal-vs-Stage3 |
3.190800E-01 |
| Normal-vs-Stage4 |
1.868160E-02 |
| Stage1-vs-Stage2 |
3.727600E-02 |
| Stage1-vs-Stage3 |
5.718000E-01 |
| Stage1-vs-Stage4 |
4.005600E-02 |
| Stage2-vs-Stage3 |
2.843600E-01 |
| Stage2-vs-Stage4 |
7.639600E-01 |
| Stage3-vs-Stage4 |
2.090600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.523800E-02 |
| Normal-vs-AfricanAmerican |
2.150000E-02 |
| Normal-vs-Asian |
4.651400E-01 |
| Caucasian-vs-AfricanAmerican |
2.194800E-01 |
| Caucasian-vs-Asian |
6.160800E-01 |
| AfricanAmerican-vs-Asian |
7.864600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.434400E-01 |
| Normal-vs-Female |
2.284100E-02 |
| Male-vs-Female |
1.547450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.701830E-01 |
| Normal-vs-Extreme_Weight |
3.501400E-01 |
| Normal-vs-Obese |
3.258800E-01 |
| Normal-vs-Extreme_Obese |
5.892200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.421200E-01 |
| Normal_Weight-vs-Obese |
6.274800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.932600E-01 |
| Extreme_Weight-vs-Obese |
7.925800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.426300E-02 |
| Obese-vs-Extreme_Obese |
1.574210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.820800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.897800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.391630E-01 |
| Normal-vs-Age(81-100Yrs) |
9.273400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.089200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.056200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.366600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.871400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.009400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.607400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.366800E-01 |
| Normal-VS-Type2 PRCC |
1.184120E-02 |
| Normal-VS-KIRP CIMP |
9.332200E-01 |
| Normal-VS-Unclassified PRCC |
9.507800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.366500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.943800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.617420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.248800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.186800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.288000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.561400E-01 |
| Normal-vs-N1 |
2.312600E-01 |
| Normal-vs-N2 |
3.669200E-01 |
| N0-vs-N1 |
7.504800E-01 |
| N0-vs-N2 |
3.760800E-01 |
| N1-vs-N2 |
3.944600E-01 |
|
|
